BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28555936)

  • 1. Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report.
    Company-Albir MJ; Ruíz-Ramos J; Solana Altabella A; Marqués-Miñana MR; Vicent C; Poveda JL
    J Clin Pharm Ther; 2017 Dec; 42(6):774-775. PubMed ID: 28555936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam.
    Garrity LC; Turner M; Standridge SM
    Pharmacotherapy; 2014 Jul; 34(7):e128-32. PubMed ID: 24807683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological monitoring of antiepileptic drugs in epilepsy patients on haemodialysis.
    Araki K; Nakamura T; Takeuchi Y; Morozumi S; Horie K; Kobayashi Y; Kawakami O; Sobue F; Ueda T; Hamada K; Ando T; Inoue Y; Yasui K; Morozumi K; Maruyama S; Katsuno M
    Epileptic Disord; 2020 Feb; 22(1):90-102. PubMed ID: 32031531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient.
    Bahte SK; Hiss M; Lichtinghagen R; Kielstein JT
    BMC Nephrol; 2014 Apr; 15():49. PubMed ID: 24739070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic drug monitoring of levetiracetam].
    Dailly E; Bouquié R; Bentué-Ferrer D;
    Therapie; 2010; 65(1):67-70. PubMed ID: 20205999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An initial experience with therapeutic drug monitoring of levetiracetam as reported from a pediatric clinical setting in India.
    Mathew BS; Fleming DH; Thomas M; Prabha R; Saravanakumar K
    Neurol India; 2012; 60(2):146-9. PubMed ID: 22626693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M; Pong AW
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous levetiracetam in end-of-life care.
    Furtado I; Gonçalves F; Gonçalves J; Neves J
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29351934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A; Kneen R; Kumar R; Spinty S; Appleton R
    Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam in pediatrics.
    Vigevano F
    J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Levetiracetam Dosing Regimens in End-Stage Renal Disease Patients Undergoing Intermittent Hemodialysis.
    Shiue HJ; Taylor M; Sands KA
    Ann Pharmacother; 2017 Oct; 51(10):862-865. PubMed ID: 28582998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy.
    Freitas-Lima P; Alexandre V; Pereira LR; Feletti F; Perucca E; Sakamoto AC
    Epilepsy Res; 2011 Mar; 94(1-2):117-20. PubMed ID: 21282041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG; Hirsch E
    Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA
    Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic model of levetiracetam in Korean neonates with seizures
.
    Jung YS; Lee SM; Park MS; Park K
    Int J Clin Pharmacol Ther; 2018 May; 56(5):217-223. PubMed ID: 29393846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam rectal administration in healthy dogs.
    Peters RK; Schubert T; Clemmons R; Vickroy T
    J Vet Intern Med; 2014; 28(2):504-9. PubMed ID: 24417468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
    Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary efficacy of levetiracetam in children.
    Glauser TA; Dulac O
    Epileptic Disord; 2003 May; 5 Suppl 1():S45-50. PubMed ID: 12915341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.